Arneth B
Cells. 2025; 14(4).
PMID: 39996755
PMC: 11853995.
DOI: 10.3390/cells14040283.
Lin G, Peng H, Yin B, Xu C, Zhao Y, Liu A
PLoS One. 2024; 19(12):e0316254.
PMID: 39724279
PMC: 11670984.
DOI: 10.1371/journal.pone.0316254.
Forrester J, McMenamin P
Eye (Lond). 2024; 39(3):468-477.
PMID: 39653763
PMC: 11794555.
DOI: 10.1038/s41433-024-03512-4.
Wu J, Song L, Lu M, Gao Q, Xu S, Zhou P
MedComm (2020). 2024; 5(7):e613.
PMID: 38898995
PMC: 11185949.
DOI: 10.1002/mco2.613.
Paganelli R, Di Lizia M, DUrbano M, Gatta A, Paganelli A, Amerio P
Biomedicines. 2023; 11(6).
PMID: 37371700
PMC: 10296089.
DOI: 10.3390/biomedicines11061605.
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson's disease.
Zhuo Y, Li X, He Z, Lu M
Stem Cell Res Ther. 2023; 14(1):80.
PMID: 37041580
PMC: 10091615.
DOI: 10.1186/s13287-023-03280-0.
Physiological and Pathophysiological Roles of IgM Fc Receptor (FcµR) Isoforms.
Kubagawa H, Clark C, Skopnik C, Mahmoudi Aliabadi P, Al-Qaisi K, Teuber R
Int J Mol Sci. 2023; 24(6).
PMID: 36982860
PMC: 10058298.
DOI: 10.3390/ijms24065728.
Neuroprotective Panel of Olive Polyphenols: Mechanisms of Action, Anti-Demyelination, and Anti-Stroke Properties.
Grubic Kezele T, Curko-Cofek B
Nutrients. 2022; 14(21).
PMID: 36364796
PMC: 9654510.
DOI: 10.3390/nu14214533.
Activation of Nrf2 to Optimise Immune Responses to Intracerebral Haemorrhage.
Loan J, Salman R, McColl B, Hardingham G
Biomolecules. 2022; 12(10).
PMID: 36291647
PMC: 9599325.
DOI: 10.3390/biom12101438.
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect.
Wang H, Guo H, Yang J, Liu Y, Liu X, Zhang Q
Exp Hematol Oncol. 2022; 11(1):60.
PMID: 36138486
PMC: 9493169.
DOI: 10.1186/s40164-022-00315-9.
A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy.
Liu Z, Ren Y, Weng S, Xu H, Li L, Han X
Front Immunol. 2022; 13:809761.
PMID: 35140720
PMC: 8818678.
DOI: 10.3389/fimmu.2022.809761.
Differences between Human and Mouse IgM Fc Receptor (FcµR).
Kubagawa H, Skopnik C, Al-Qaisi K, Calvert R, Honjo K, Kubagawa Y
Int J Mol Sci. 2021; 22(13).
PMID: 34209905
PMC: 8267714.
DOI: 10.3390/ijms22137024.
Rewriting History: Epigenetic Reprogramming of CD8 T Cell Differentiation to Enhance Immunotherapy.
Zebley C, Gottschalk S, Youngblood B
Trends Immunol. 2020; 41(8):665-675.
PMID: 32624330
PMC: 7395868.
DOI: 10.1016/j.it.2020.06.008.
